Biomea Fusion Inc BMEA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
12.62UNCH (UNCH)
Volume
15,019
Close
12.62quote price arrow up+0.38 (+3.10%)
Volume
432,739
52 week range
8.12 - 43.69
Loading...
  • Open12.24
  • Day High12.70
  • Day Low12.00
  • Prev Close12.24
  • 52 Week High43.69
  • 52 Week High Date06/08/23
  • 52 Week Low8.12
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap453.621M
  • Shares Out35.94M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta-0.35
  • YTD % Change-13.09

KEY STATS

  • Open12.24
  • Day High12.70
  • Day Low12.00
  • Prev Close12.24
  • 52 Week High43.69
  • 52 Week High Date06/08/23
  • 52 Week Low8.12
  • 52 Week Low Date11/13/23
  • Market Cap453.621M
  • Shares Out35.94M
  • 10 Day Average Volume0.61M
  • Dividend-
  • Dividend Yield-
  • Beta-0.35
  • YTD % Change-13.09

RATIOS/PROFITABILITY

  • EPS (TTM)-3.57
  • P/E (TTM)-3.54
  • Fwd P/E (NTM)-3.11
  • EBITDA (TTM)-135.521M
  • ROE (TTM)-116.52%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/04/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biomea Fusion Inc

 

Profile

MORE
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines...
Thomas Butler
Chairman of the Board, Chief Executive Officer, Co-Founder
Rainer Erdtmann
President, Co-Founder, Chief Operating Officer, Director
Franco Valle
Chief Financial Officer
Address
900 Middlefield Road, 4Th Floor
Redwood City, CA
94063
United States

Top Peers

SYMBOLLASTCHG%CHG
SLDB
Solid Biosciences Inc
9.12+0.17+1.90%
REPL
Replimune Group Inc
5.94-0.50-7.76%
TRML
Tourmaline Bio Inc
14.56-0.48-3.19%
AURA
Aura Biosciences Inc
7.10-0.17-2.34%
TERN
Terns Pharmaceuticals Inc
6.25+0.35+5.93%